We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
-5.07%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$4.94B
AUM Growth
-$256M
(-4.9%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
23%
Holding
310
New
46
Increased
109
Reduced
88
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$52.6M |
| 2 |
UnitedHealth
UNH
|
+$48.5M |
| 3 |
Eli Lilly
LLY
|
+$40.2M |
| 4 |
Bank of America
BAC
|
+$33.6M |
| 5 |
Pfizer
PFE
|
+$32.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$55.2M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$45M |
| 3 |
Zimmer Biomet
ZBH
|
+$35.5M |
| 4 |
Cooper Companies
COO
|
+$35.5M |
| 5 |
Roper Technologies
ROP
|
+$31.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.89% |
| 2 | Technology | 24.22% |
| 3 | Financials | 21.01% |
| 4 | Communication Services | 9.7% |
| 5 | Consumer Discretionary | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSNU
176
DELISTED
Tyson Foods, Inc.
TSNU
| $4.64M | 0.09% |
89,100
+10,500
| +13% | +$541K |
|
177
8x8 Inc
EGHT
$262M
| $4.54M | 0.09% |
+548,608
| New | +$4.54M |
|
178
Radware
RDWR
$1.23B
| $4.38M | 0.09% |
269,539
-426,979
| -61% | -$8.13M |
|
179
RingCentral
RNG
$4.5B
| $4.25M | 0.09% |
234,520
+101,733
| +77% | +$1.85M |
|
180
Veeva Systems
VEEV
$31.6B
| $4.17M | 0.08% |
+178,257
| New | +$4.65M |
|
181
Gilead Sciences
GILD
$162B
| $4.15M | 0.08% |
42,304
+7,454
| +21% | +$828K |
|
|
DATA
182
DELISTED
Tableau Software, Inc.
DATA
| $4.14M | 0.08% |
51,950
+39,156
| +306% | +$4.06M |
|
|
CY
183
DELISTED
Cypress Semiconductor
CY
| $3.91M | 0.08% |
+458,676
| New | +$4.81M |
|
184
Intuit
INTU
$83.1B
| $3.9M | 0.08% |
43,923
-32,645
| -43% | -$3.17M |
|
|
OAK
185
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $3.84M | 0.08% |
77,500
| – | – |
|
186
Ziff Davis
ZD
$1.93B
| $3.71M | 0.08% |
60,206
-24,709
| -29% | -$1.5M |
|
187
East-West Bancorp
EWBC
$17.8B
| $3.67M | 0.07% |
95,600
-53,905
| -36% | -$2.28M |
|
|
MBLY
188
DELISTED
Mobileye N.V.
MBLY
| $3.67M | 0.07% |
80,638
+47,955
| +147% | +$2.63M |
|
|
PPBI
189
DELISTED
Pacific Premier Bancorp
PPBI
| $3.5M | 0.07% |
172,514
+22,544
| +15% | +$429K |
|
|
CVT
190
DELISTED
CVENT, INC.
CVT
| $3.34M | 0.07% |
99,412
-126,198
| -56% | -$3.81M |
|
|
BITA
191
DELISTED
Bitauto Holdings Limited
BITA
| $3.29M | 0.07% |
+110,544
| New | +$3.76M |
|
|
AXON
192
Axon Enterprise
AXON
$42.4B
| $3.04M | 0.06% |
138,037
+73,110
| +113% | +$1.93M |
|
193
Biogen
BIIB
$29.5B
| $2.76M | 0.06% |
9,453
+2,022
| +27% | +$668K |
|
194
American Express
AXP
$229B
| $2.74M | 0.06% |
36,975
-14,056
| -28% | -$1.08M |
|
195
Cardinal Health
CAH
$53.7B
| $2.69M | 0.05% |
35,000
-7,000
| -17% | -$585K |
|
|
APIC
196
DELISTED
Apigee Corporation Common Stock
APIC
| $2.43M | 0.05% |
231,729
+66,959
| +41% | +$580K |
|
197
Corning
GLW
$123B
| $2.29M | 0.05% |
133,967
-79,541
| -37% | -$1.43M |
|
198
Stratasys
SSYS
$700M
| $2.27M | 0.05% |
+85,532
| New | +$2.64M |
|
|
ICPT
199
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.23M | 0.05% |
13,459
+3,631
| +37% | +$799K |
|
200
Brookdale Senior Living
BKD
$3.69B
| $2.22M | 0.04% |
96,667
+6,000
| +7% | +$177K |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Polar Capital held 310 positions worth $4.94B, down 4.9% from $5.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Polar Capital deployed $155M of net new capital in Q3 2015, opening 46 new positions and adding to 109 existing holdings. Its largest new stake was Allergan plc: 171,100 shares worth $46.5M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $45M trimmed.
- Polar Capital's largest Q3 2015 buy was Allergan plc: 171,100 shares worth $46.5M.
- Polar Capital added most to UnitedHealth in Q3 2015, an estimated $48.5M increase.
- Polar Capital's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $45M.
- Polar Capital fully exited Time Warner Inc in Q3 2015, selling an estimated $55.2M.
- Polar Capital's ten largest holdings make up 23% of its $4.94B portfolio in Q3 2015.
- Polar Capital opened 46 new positions and closed 39 in Q3 2015.
- Polar Capital's portfolio value fell 4.9% quarter-over-quarter to $4.94B.
Based on Polar Capital's 13F filing for Q3 2015, filed 16 Nov 2015.